PCI Pharma Services
PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. With 35 sites across Australia, Canada, North America, the UK and Europe and over 8000+ dedicated employees, together, delivering life changing therapies to patients. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
Highlights include environmental goals based on climate science, workforce empowerment, focus on local partnerships and supply chain resiliency 27 March 2024 -- Pennsylvania, US -- PCI Pharma Services, a leading global contract development and manufacturing organisation (CDMO), has released its first Environmental, Social & Governance (ESG) Report. A detailed overview of PCI’s multifaceted sustainability journey,...
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
World-leading CDMO Offers Highly Specialised Experience Bringing Complex Formulations to Market Quickly and Will Support Clinical Trials of Aldena’s siRNA-based Injectable Treatment 19 October 2023 –Philadelphia, US -- Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a world-leading global contract development and manufacturing organisation...
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PHILADELPHIA - April 18, 2023 -PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and...
Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
SHORT HILLS, NJ. June 16, 2022--(BUSINESS WIRE)-- Humanigen, Inc. (Nasdaq: HGEN) ('Humanigen'), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ëcytokine storm,í today announced it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization...
PCI Strengthens Position in Europe with Investment in Ireland
Philadelphia, PA - August 27, 2019 - PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and expand its European foothold.
PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility
Philadelphia, PA - June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
PCI Pharma Services Announces Organization Updates
Philadelphia, PA - May 20, 2019 - PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the companyís future vision, strategy and growth.
Clinical Trial Supply West Coast Conference 2019
Philadelphia, USA - April 24, 2019. This yearís Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
PCI Announces Expansion of High Potent Tableting and Powder Modification Capacity
Philadelphia, USA - March 25, 2019 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, has announced further investment to expand its flagship manufacturing center in Tredegar, Wales.
PCI Pharma Services Appoints New Chief Financial Officer SVP Serge Dupuis
Philadelphia, PA - 22 March, 2019. Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer (CFO).
